Related Experiment Video
Updated: Apr 30, 2026

Endothelialized Microfluidics for Studying Microvascular Interactions in Hematologic Diseases
Published on: June 22, 2012
Biological basis and pathological relevance of microvascular thrombosis
Susanne Pfeiler1, Steffen Massberg2, Bernd Engelmann1
1Institut für Laboratoriumsmedizin, Ludwig-Maximilians-Universität, Munich, Germany.
Abstract:
Microvascular thrombosis indicates a pathological occlusion of microvessels by fibrin- and/or platelet-rich thrombi. It is observed during systemic infections, cancer, myocardial infarction, stroke, neurodegenerative diseases and in thrombotic microangiopathies. Microvessel thrombosis can cause greatly differing symptoms that range from limited changes in plasma coagulation markers to severe multi-organ failure. Because microvessel thrombi are difficult to detect and often occur only transiently, their importance for disease development and host biology is likely markedly under-appreciated. Recently, clear indications for a biological basis of microvascular thrombosis have been obtained. During systemic infections microvessel thrombosis can mediate an intravascular innate immune response (immunothrombosis). This biological form of thrombosis is based on the generation of fibrin inside blood vessels and is critically triggered by neutrophils and their interactions with platelets which result in the release of neutrophil extracellular traps (extracellular nucleosomes). Immunothrombosis is critically supported by neutrophil elastase and the activator molecules of blood coagulation tissue factor and factor XII. Identification of the biological driving forces of microvascular thrombosis should help to elucidate the mechanisms promoting pathological vessel occlusions in both microvessels and large vessels.
Insights
Microvascular thrombosis, the pathological occlusion of small blood vessels, is often underappreciated. Recent research reveals its role in the innate immune response, termed immunothrombosis, during infections.
Area of Science:
- Vascular Biology
- Immunology
- Hematology
Background:
- Microvascular thrombosis involves pathological occlusion of microvessels by fibrin and platelet-rich thrombi.
- It is implicated in systemic infections, cancer, myocardial infarction, stroke, neurodegenerative diseases, and thrombotic microangiopathies.
- The transient nature and detection difficulty of microthrombi lead to underappreciation of their role in disease.
Purpose of the Study:
- To elucidate the biological basis and mechanisms of microvascular thrombosis.
- To understand the role of microvascular thrombosis in systemic infections, specifically immunothrombosis.
- To identify key molecular players driving microvascular thrombosis.
Main Methods:
- Review of recent findings on microvascular thrombosis.
- Analysis of the role of neutrophils, platelets, and extracellular nucleosomes in immunothrombosis.
- Investigation of the involvement of neutrophil elastase, tissue factor, and factor XII in blood coagulation.
Main Results:
- Microvascular thrombosis can mediate an intravascular innate immune response (immunothrombosis) during systemic infections.
- Immunothrombosis involves fibrin generation within blood vessels, triggered by neutrophil-platelet interactions and neutrophil extracellular traps.
- Neutrophil elastase, tissue factor, and factor XII are critical for supporting immunothrombosis.
Conclusions:
- Microvascular thrombosis has a significant biological basis, particularly as an innate immune response (immunothrombosis).
- Understanding the drivers of microvascular thrombosis, including neutrophil-derived factors, is crucial for elucidating pathological vessel occlusions.
- This knowledge may aid in understanding mechanisms of thrombosis in both microvessels and large vessels.
More Related Videos
09:19In Vitro Microfluidic Disease Model to Study Whole Blood-Endothelial Interactions and Blood Clot Dynamics in Real-Time
Published on: May 24, 2020
08:21Author Spotlight: A Pharmacodissection Approach to Uncover Mechanisms in Cardiovascular Disease Risk Populations
Published on: July 21, 2023
Related Concept Videos
Venous Thrombosis I: Introduction
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Ischemic Stroke ll: Pathophysiology
Overview of the Vascular System
Mechanism of Angiogenesis
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies